Plant · Scientific monograph
Gentiana lutea
Yellow gentian
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Digestive traditional use, Topical skin research
Research overview
Historical use
EMA recognizes traditional use of specified gentian-root preparations for temporary loss of appetite and mild dyspeptic/gastrointestinal complaints [1].
Modern research context
The EMA conclusion is based on traditional use; an uncontrolled 205-person study did not support firm efficacy conclusions [1]. A 22-person, 14-day split-face study examined a topical eye-area cream, which does not support oral digestive claims [2].
Adverse effects
EMA reported no side effects in the assessment material at that time, but this is not proof of safety across products or populations [1].
Contraindications
Use only within the EMA's specified root preparations and traditional-use scope. The topical skin trial does not establish oral use [1,2].
Clinical and phytochemical data
Used part
Dried/comminuted root or specified ethanol extracts for EMA scope; separate topical extract in the skin study [1,2].
Primary active compounds
Gentiopicroside and other bitter secoiridoids are reported in the EMA assessment [1].
Mechanism of action
The topical study explored pathways in skin models; it does not establish a clinical mechanism for oral gentian preparations [2].
Pharmacokinetics
Absorption
EMA reports no clinical pharmacokinetic data for gentian root [1].
Distribution
No clinical PK data available [1].
Metabolism
No clinical PK data available [1].
Excretion
No clinical PK data available [1].
Safety and interactions
Drug interactions
No clinical interaction evidence sufficient to grade interactions was identified by EMA [1].
Toxicity
Clinical safety data are limited; EMA assessment is not a comprehensive long-term toxicity demonstration [1].
Special precautions
Pregnancy
EMA states use in children/adolescents under 18 is not recommended; medicinal use in pregnancy is insufficiently established [1].
Lactation
Lactation safety is not established [1].
Hepatic impairment
No hepatic impairment-specific evidence identified.
Renal impairment
No renal impairment-specific evidence identified.
Sources and references
- [1] EMA/HMPC. European Union herbal monograph on Gentiana lutea L., radix, revision 1. EMA/HMPC/607861/2017.
- [2] Jean-Yves Berthon et al. In vitro, ex vivo and clinical approaches to evaluate the potential effect of Gentiana lutea extract on skin. International Journal of Cosmetic Science. 2023;45(5):688–698. PMID: 37365865. DOI: 10.1111/ics.12878.